Mutational spectra of human cancer
- 24 March 2009
- journal article
- review article
- Published by Springer Nature in Human Genetics
- Vol. 125 (5-6) , 493-506
- https://doi.org/10.1007/s00439-009-0657-2
Abstract
The purpose of this review is to summarize the evidence that can be used to reconstruct the etiology of human cancers from mutations found in tumors. Mutational spectra of the tumor suppressor gene p53 (TP53) are tumor specific. In several cases, these mutational spectra can be linked to exogenous carcinogens, most notably for sunlight-associated skin cancers, tobacco-associated lung cancers, and aristolochic acid-related urothelial tumors. In the TP53 gene, methylated CpG dinucleotides are sequences selectively targeted by endogenous and exogenous mutagenic processes. Recent high-throughput sequencing efforts analyzing a large number of genes in cancer genomes have so far, for the most part, produced mutational spectra similar to those in TP53 but have unveiled a previously unrecognized common G to C transversion mutation signature at GpA dinucleotides in breast cancers and several other cancers. Unraveling the origin of these G to C mutations will be of importance for understanding cancer etiology.Keywords
This publication has 120 references indexed in Scilit:
- Somatic mutations affect key pathways in lung adenocarcinomaNature, 2008
- Second-hand smoke and human lung cancerThe Lancet Oncology, 2008
- Translating insights from the cancer genome into clinical practiceNature, 2008
- The Catalogue of Somatic Mutations in Cancer (COSMIC)Current Protocols in Human Genetics, 2008
- A transforming mutation in the pleckstrin homology domain of AKT1 in cancerNature, 2007
- Patterns of somatic mutation in human cancer genomesNature, 2007
- Epidermal growth factor receptor mutations in lung cancerNature Reviews Cancer, 2007
- Mutations of the BRAF gene in human cancerNature, 2002
- The Hallmarks of CancerCell, 2000
- Molecular basis of base substitution hotspots in Escherichia coliNature, 1978